financetom
Market
financetom
/
Market
/
Exchange-Traded Funds, US Equities Rise in Friday Midday Trading
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exchange-Traded Funds, US Equities Rise in Friday Midday Trading
Nov 22, 2024 10:36 AM

01:05 PM EST, 11/22/2024 (MT Newswires) -- Broad Market Indicators

Broad-market exchange-traded funds IWM and IVV were higher. Actively traded Invesco QQQ Trust (QQQ) rose fractionally.

US benchmark indexes rose in midday Friday trading and appear to be on track to erase a decline last week.

Energy

iShares US Energy ETF (IYE) and Energy Select Sector SPDR (XLE) both climbed around 0.4%.

Technology

Technology Select Sector SPDR ETF (XLK) fell 0.2%; iShares US Technology ETF (IYW) and iShares Expanded Tech Sector ETF (IGM) also dropped.

SPDR S&P Semiconductor (XSD) advanced 1.2%, and iShares Semiconductor (SOXX) dropped 0.3%.

Financial

Financial Select Sector SPDR (XLF) gained 0.9%. Direxion Daily Financial Bull 3X Shares (FAS) was up 2.6%, and its bearish counterpart Direxion Daily Financial Bear 3X Shares (FAZ) dropped 2.7%.

Commodities

Crude oil was up 1.4%, and the United States Oil Fund (USO) rose 1.3%. Natural gas slumped 5.9%, while the United States Natural Gas Fund (UNG) tumbled 6.4%.

Gold added 1.2% on Comex, and SPDR Gold Shares (GLD) gained 1.3%. Silver rose 1.3%, while iShares Silver Trust (SLV) was 1.6% higher.

Consumer

Consumer Staples Select Sector SPDR (XLP) added 0.8%; Vanguard Consumer Staples ETF (VDC) and iShares Dow Jones US Consumer Goods (IYK) also rose.

Consumer Discretionary Select Sector SPDR (XLY) gained 1.6%; retail fund VanEck Vectors Retail ETF (RTH) and SPDR S&P Retail (XRT) advanced.

Health Care

Health Care Select Sector SPDR (XLV) rose 0.3%, while iShares US Healthcare (IYH) and Vanguard Health Care ETF (VHT) also climbed. IShares NASDAQ Biotechnology ETF (IBB) gained 1.6%.

Industrial

Select Sector SPDR-Industrial (XLI) rose 1.2%, Vanguard Industrials (VIS) and iShares US Industrials (IYJ) also advanced.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Investors Parse Earnings Reports With US Equity Futures Flat Tuesday Pre-Bell
Investors Parse Earnings Reports With US Equity Futures Flat Tuesday Pre-Bell
Oct 21, 2025
08:09 AM EDT, 10/21/2025 (MT Newswires) -- US stock futures were little changed in Tuesday's premarket session as investors parsed pre-market earning reports and looked ahead to reports coming out later in the day and week. General Motors (GM), Coca-Cola (KO), Lockheed Martin (LMT), and Phillip Morris (PM) all reported earnings beats pre-bell. Dow Jones Industrial Average futures were up...
US STOCKS-Wall Street futures subdued as earnings season gains momentum
US STOCKS-Wall Street futures subdued as earnings season gains momentum
Oct 21, 2025
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.) * Futures flat: Dow up 0.03%, S&P 500 up 0.03%, Nasdaq down 0.02% * Fluor gains after reports Starboard has taken nearly 5% stake * Health insurers rise after upbeat results from Elevance (Updates prices) By Pranav Kashyap and...
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday as Rate-Cut Bets Offset by Earnings Watch
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Tuesday as Rate-Cut Bets Offset by Earnings Watch
Oct 21, 2025
08:32 AM EDT, 10/21/2025 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was up 0.04% and the actively traded Invesco QQQ Trust (QQQ) was 0.02% higher in Tuesday's premarket activity as hopes of an interest rate cut were offset by a focus on corporate earnings. US stock futures were mixed, with S&P...
XORTX Therapeutics Down Near 10% In US Premarket As Prices US$1.1 Million Registered Direct Offering
XORTX Therapeutics Down Near 10% In US Premarket As Prices US$1.1 Million Registered Direct Offering
Oct 21, 2025
08:13 AM EDT, 10/21/2025 (MT Newswires) -- XORTX Therapeutics ( XRTX ) , a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, was down near 10% in US premarket after announcing Tuesday that it has entered into a securities purchase agreement with an institutional investor for the purchase and sale of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved